Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting

NCT00409799 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Tibia Plateau Fractures

Interventions

DRUG: I-0401 (a new bone graft substitute)

Sponsor

Kuros Biosurgery AG